The safety of statins in clinical practice
作者： Jane Armitage
DOI: 10.1016/S0140-6736(07)60716-8
关键词:
摘要: Statins are effective cholesterol-lowering drugs that reduce the risk of cardiovascular disease events (heart attacks, strokes, and the need for arterial revascularisation). Adverse …
archivestsc.com
elsevier.com
lancet.com 参考文章(124)
J M Armitage, A J Hauer, S E Parish, R Collins, A Lawson, K R Wallendszus, A C Keech, Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group. British Journal of Clinical Pharmacology. ,vol. 42, pp. 483- 490 ,(1996) , 10.1046/J.1365-2125.1996.4391.X
J Wardle, J Armitage, R Collins, K Wallendszus, A Keech, A Lawson, Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. BMJ. ,vol. 313, pp. 75- 78 ,(1996) , 10.1136/BMJ.313.7049.75
Feng Z, Campbell Tc, Li J, Boreham J, Youngman L, Peto R, Chen J, Diet life-style and mortality in China: a study of the characteristics of 65 Chinese counties. Oxford England Oxford University Press 1990.. ,(1990)
Salim Yusuf, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary The Lancet. ,vol. 360, pp. 7- 22 ,(2002)
Jonathan A. Tobert, Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nature Reviews Drug Discovery. ,vol. 2, pp. 517- 526 ,(2003) , 10.1038/NRD1112
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet. ,vol. 361, pp. 2005- 2016 ,(2003) , 10.1016/S0140-6736(03)13636-7
, High-dose atorvastatin after stroke or transient ischemic attack. The New England Journal of Medicine. ,vol. 355, pp. 549- 559 ,(2006) , 10.1056/NEJMOA061894
Curt D Furberg, Bertram Pitt, Withdrawal of cerivastatin from the world market Trials. ,vol. 2, pp. 205- 207 ,(2001) , 10.1186/CVM-2-5-205
H. Holdaas, B. Fellström, E. Cole, G. Nyberg, A.G. Olsson, T.R. Pedersen, S. Madsen, C. Grönhagen-Riska, H.-H. Neumayer, B. Maes, P. Ambühl, A. Hartmann, B. Staffler, A.G. Jardine, , Long term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study American Journal of Transplantation. ,vol. 5, pp. 2929- 2936 ,(2005) , 10.1111/J.1600-6143.2005.01105.X
Donald B. Hunninghake, HMG CoA reductase inhibitors Current Opinion in Lipidology. ,vol. 3, pp. 22- 28 ,(1992) , 10.1097/00041433-199202000-00005